Original Research

Empagliflozin in Type 2 Diabetes Mellitus Patients with High Cardiovascular Risk: A Model-Based Cost-Utility Analysis in China

Men P, Liu T, Zhai S

Diabetes, Metabolic Syndrome and Obesity 2020, 13:2823-2831

Published Date: 11 August 2020